13,990.00
-200(-1.41%)
Currency In KRW
Sector
Healthcare
Industry
Biotechnology
Employees
553
First IPO Date
August 07, 2001
| Name | Title | Pay | Year Born |
| Jung-Tak Moon | Chief Executive Officer | 0 | 1966 |
| Byung-In Lee | Head of Bus. Operation Division and Director | 0 | 1965 |
| Doo-Hyun Kim | Vice President | 0 | 1952 |
| Jung-Jin Lee | Head of Bio-Tech Research Center and Director | 0 | 1964 |
| Jung-Won Seo | Head of Bio Processing Division and Director | 0 | 1962 |
| Hyuk-Jong Lee | Managing Director | 0 | 1969 |
| Myung-Cheol Lee | Managing Director | 0 | 1958 |
| Soo-Yong Jin | Managing Director | 0 | 1968 |
| Won-Seok Kim | Head of Production Division and Director | 0 | 1963 |
| Young-Cheol Son | Head of Management Support Division and Director | 0 | 1964 |
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.